Authors
Loading...
Randomized trial shows reduced neutralizing potency in vaccine recipients compared to convalescents, suggesting changes in antibody targeting.
Oishi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: